SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 13.76 |
| Enterprise Value ($M) | 4.91 |
| Book Value ($M) | 15.03 |
| Book Value / Share | 1.09 |
| Price / Book | 0.92 |
| NCAV ($M) | 0.00 |
| NCAV / Share | 0.00 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.23 |
| Return on Assets (ROA) | 0.25 |
| Return on Equity (ROE) | 0.42 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | -0.10 |
| Current Ratio | 1.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | n/a |
| Assets | n/a |
| Liabilities | n/a |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | n/a |
| Operating Income | 0.00 |
| Net Income | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | n/a |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Streeterville Capital LLC | 0.00 | -100.00 | |
| 13G/A | Forsakringsaktiebolaget Avanza Pension | 1.00 | 46.68 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,594,402 | 51,152,304 | 32.44 | |
| 42,127 | 353,674 | 11.91 | |
| 18,393 | 186,042 | 9.89 | |
| 2,670 | 14,617 | 18.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SONN – Sonnet BioTherapeutics Holdings, Inc. | SPRB – Spruce Biosciences, Inc. |
| SRZN – Surrozen, Inc. | SXTP – 60 Degrees Pharmaceuticals, Inc. |
| SYBX – Synlogic, Inc. |
Financial data and stock pages provided by
Fintel.io